These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15030265)

  • 1. Chlamydia pneumoniae and coronary artery disease: legitimized linkages?
    Higgins JP; Higgins JA; Higgins PM; Ahuja S; Higgins DL
    Expert Rev Cardiovasc Ther; 2003 Sep; 1(3):367-84. PubMed ID: 15030265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chlamydia pneumoniae, atherosclerosis, and coronary disease].
    Monno R; Di Biase M; Costi A; de Nicolò T; Correale M; Bolognese P; Losacco G
    Ital Heart J Suppl; 2003 May; 4(5):383-97. PubMed ID: 12848076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chlamydia pneumoniae infection increases the risk of coronary artery disease in the patients with dyslipidemia].
    Sun YH; Pei WD; Wu YJ; Ye SD; Wang GG; Gao RL; Yang YJ
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1990-3. PubMed ID: 15730813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atherosclerosis and inflammation--role of chlamydia pneumoniae infection what do we know to date?].
    Fudal M; Wilczewski P
    Wiad Lek; 2004; 57(3-4):151-5. PubMed ID: 15307523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between Chlamydophila pneumoniae IgG titer and coronary atherosclerosis.
    Kalay N; Kutukoglu I; Ozdogru I; Kilic H; Cetinkaya Y; Eryol NK; Karakaya E; Oguzhan A
    Cardiol J; 2008; 15(3):245-51. PubMed ID: 18651417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlamydia pneumoniae and coronary artery disease: the antibiotic trials.
    Higgins JP
    Mayo Clin Proc; 2003 Mar; 78(3):321-32. PubMed ID: 12630585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Chlamydia pneumoniae in atherosclerosis.
    Watson C; Alp NJ
    Clin Sci (Lond); 2008 Apr; 114(8):509-31. PubMed ID: 18336368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is seropositivity enough to show the association between coronary artery disease and Chlamydia pneumoniae and Helicobacter pylori infection?
    Yetkin G
    Int J Cardiol; 2006 Nov; 113(3):432-4. PubMed ID: 16325945
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chlamydia pneumoniae - causal pathogen or fortuitous witness of atherosclerosis progression?].
    Tracz W
    Kardiol Pol; 2009 Sep; 67(9):987-8. PubMed ID: 19938364
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction between Chlamydia pneumoniae seropositivity, inflammation and risk factors for atherosclerosis in patients with severe coronary stenosis.
    Yavuz MT; Yavuz O; Yazici M; Guler S; Ozhan H; Albayrak S; Coskun A
    Scand J Clin Lab Invest; 2006; 66(6):523-34. PubMed ID: 17000560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of infection in the pathogenesis of atherosclerosis].
    Banach M; Markuszewski L; Zasłonka J; Grzegorczyk J; Okoński P; Jegier B
    Przegl Epidemiol; 2004; 58(4):671-6. PubMed ID: 15810509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia pneumoniae infection and atherosclerosis: methodological considerations.
    Kuo CC; Campbell LA; Rosenfeld ME
    Circulation; 2002 Jan; 105(4):E34. PubMed ID: 11815446
    [No Abstract]   [Full Text] [Related]  

  • 13. Protective effect of doxycycline use on coronary artery disease?
    Kardara M; Papazafiropoulou A; Katsakiori P; Petropoulos C; Jelastopulu E
    J Infect; 2006 Apr; 52(4):243-6. PubMed ID: 16176834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic therapy for coronary heart disease: the myth and the reality.
    Kuppuswamy VC; Gupta S
    Timely Top Med Cardiovasc Dis; 2006 Jan; 10():E2. PubMed ID: 16404482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azithromycin reduces Chlamydia pneumoniae-induced attenuation of eNOS and cGMP production by endothelial cells.
    Bouwman JJ; Visseren FL; Bevers LM; van der Vlist WE; Bouter KP; Diepersloot RJ
    Eur J Clin Invest; 2005 Sep; 35(9):573-82. PubMed ID: 16128864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-infection ratios versus inflammation, growth factors and progression of early atheromas.
    Higuchi ML; Góis JM; Reis MM; Higuchi-Dos-Santos MH; Diament J; Sousa JM; Ramires JA; Oliveira SA
    APMIS; 2006 May; 114(5):338-44. PubMed ID: 16725009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Part of Chlamydia pneumoniae in atherosclerosis and exacerbation of chronic obstructive pulmonary disease and asthma].
    Azzouzi N; Elhataoui M; Bakhatar A; Takourt B; Benslimane A
    Ann Biol Clin (Paris); 2005; 63(2):179-84. PubMed ID: 15771975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?
    Campbell LA; Kuo CC
    Nat Rev Microbiol; 2004 Jan; 2(1):23-32. PubMed ID: 15035006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroepidemiology in Chlamydia pneumoniae-- atherosclerosis association.
    Saikku P
    Eur Heart J; 2002 Feb; 23(4):263-4. PubMed ID: 11812058
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation of hyperhomocysteinaemia and Chlamydia pneumoniae IgG seropositivity with coronary artery disease in a general population.
    Nabipour I; Vahdat K; Jafari SM; Amiri M; Shafeiae E; Riazi A; Amini AL; Pazoki R; Sanjdideh Z
    Heart Lung Circ; 2007 Dec; 16(6):416-22. PubMed ID: 17974477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.